These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Studies on the pathogenesis of type I diabetes mellitus--destruction of pancreatic beta cells by cytotoxic T lymphocytes in nonobese diabetic mice]. Nagata M Nihon Naibunpi Gakkai Zasshi; 1990 Mar; 66(3):145-58. PubMed ID: 2189754 [TBL] [Abstract][Full Text] [Related]
6. Autoantibodies in the sera from newly diagnosed diabetic nod mice: evidence against cross-reactivity with a putative beta-cell surface autoantigen. Formby B; Miller N Diabetes Res; 1990 Jan; 13(1):13-7. PubMed ID: 2097091 [TBL] [Abstract][Full Text] [Related]
7. Ontogeny of islet cell antibodies, insulin autoantibodies and insulitis in the non-obese diabetic mouse. Reddy S; Bibby NJ; Elliott RB Diabetologia; 1988 May; 31(5):322-8. PubMed ID: 3294069 [TBL] [Abstract][Full Text] [Related]
8. Induction and therapy of autoimmune diabetes in the non-obese diabetic (NOD/Lt) mouse by a 65-kDa heat shock protein. Elias D; Markovits D; Reshef T; van der Zee R; Cohen IR Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1576-80. PubMed ID: 2406723 [TBL] [Abstract][Full Text] [Related]
9. Recognition of common islet antigen by autoantibodies from NOD mice and humans with IDDM. Karounos DG; Thomas JW Diabetes; 1990 Sep; 39(9):1085-90. PubMed ID: 2200729 [TBL] [Abstract][Full Text] [Related]
10. Splenocytes from non-obese-diabetic mice binding to xenogeneic beta-cells in vitro: an early marker of cell-mediated immunity. Martignat L; Feve B; Charbonnel B; Sai P Diabete Metab; 1993; 19(6):566-74. PubMed ID: 8026608 [TBL] [Abstract][Full Text] [Related]
11. Longitudinal study of islet cell antibodies and insulin autoantibodies and development of diabetes in non-obese diabetic (NOD) mice. Reddy S; Bibby N; Elliott RB Clin Exp Immunol; 1990 Sep; 81(3):400-5. PubMed ID: 2204503 [TBL] [Abstract][Full Text] [Related]
12. Differences in adhesion markers, activation markers, and TcR in islet infiltrating vs. peripheral lymphocytes in the NOD mouse. Goldrath AW; Barber L; Chen KE; Alters SE J Autoimmun; 1995 Apr; 8(2):209-20. PubMed ID: 7612149 [TBL] [Abstract][Full Text] [Related]
13. Paradoxical lessening of autoimmune processes in non-obese diabetic mice after infection with the diabetogenic variant of encephalomyocarditis virus. Hermitte L; Vialettes B; Naquet P; Atlan C; Payan MJ; Vague P Eur J Immunol; 1990 Jun; 20(6):1297-303. PubMed ID: 2164479 [TBL] [Abstract][Full Text] [Related]
14. Predominance of T lymphocytes in pancreatic islets and spleen of pre-diabetic non-obese diabetic (NOD) mice: a longitudinal study. Miyazaki A; Hanafusa T; Yamada K; Miyagawa J; Fujino-Kurihara H; Nakajima H; Nonaka K; Tarui S Clin Exp Immunol; 1985 Jun; 60(3):622-30. PubMed ID: 3160515 [TBL] [Abstract][Full Text] [Related]
15. Flow-cytometric detection of human anti-rat insulinoma antibodies in relation to anti-human islet cell and anti-insulin antibodies. Recognition of distinct antigens by antibodies in early type I diabetes. Lander T; Nerl C; Held M; Standl E; Mehnert H Diabetes; 1989 Dec; 38(12):1557-66. PubMed ID: 2555242 [TBL] [Abstract][Full Text] [Related]
16. Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells. Mellanby RJ; Thomas D; Phillips JM; Cooke A Immunology; 2007 May; 121(1):15-28. PubMed ID: 17428252 [TBL] [Abstract][Full Text] [Related]